184 related articles for article (PubMed ID: 29101415)
1. Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits.
de Boer P; van de Schoot AJAJ; Westerveld H; Smit M; Buist MR; Bel A; Rasch CRN; Stalpers LJA
Strahlenther Onkol; 2018 Mar; 194(3):255-263. PubMed ID: 29101415
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric advantages of proton therapy compared with photon therapy using an adaptive strategy in cervical cancer.
van de Schoot AJ; de Boer P; Crama KF; Visser J; Stalpers LJ; Rasch CR; Bel A
Acta Oncol; 2016 Jul; 55(7):892-9. PubMed ID: 26934821
[TBL] [Abstract][Full Text] [Related]
3. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
[TBL] [Abstract][Full Text] [Related]
4. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of plan quality and robustness of IMPT and helical IMRT for cervical cancer.
Shang H; Pu Y; Wang W; Dai Z; Jin F
Radiat Oncol; 2020 Feb; 15(1):34. PubMed ID: 32054496
[TBL] [Abstract][Full Text] [Related]
7. Plan-library supported automated replanning for online-adaptive intensity-modulated proton therapy of cervical cancer.
Jagt TZ; Breedveld S; van Haveren R; Nout RA; Astreinidou E; Heijmen BJM; Hoogeman MS
Acta Oncol; 2019 Oct; 58(10):1440-1445. PubMed ID: 31271076
[No Abstract] [Full Text] [Related]
8. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
9. Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization.
Yoshimura T; Yamada R; Kinoshita R; Matsuura T; Kanehira T; Tamura H; Nishioka K; Yasuda K; Taguchi H; Katoh N; Kobashi K; Hashimoto T; Aoyama H
J Radiat Res; 2024 May; 65(3):369-378. PubMed ID: 38499489
[TBL] [Abstract][Full Text] [Related]
10. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
[TBL] [Abstract][Full Text] [Related]
11. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
[TBL] [Abstract][Full Text] [Related]
12. Bag and loop small bowel contouring strategies differentially estimate small bowel dose for post-hysterectomy women receiving pencil beam scanning proton therapy.
Xu MJ; Kirk M; Zhai H; Lin LL
Acta Oncol; 2016 Jul; 55(7):900-8. PubMed ID: 26927612
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric evaluation of bone marrow sparing in proton radiotherapy for cervical cancer guided by MR functional imaging.
Qin X; Gong G; Wang L; Su Y; Yin Y
Radiat Oncol; 2022 Dec; 17(1):207. PubMed ID: 36517839
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
[No Abstract] [Full Text] [Related]
15. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
16. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy.
Cozzi L; Dinshaw KA; Shrivastava SK; Mahantshetty U; Engineer R; Deshpande DD; Jamema SV; Vanetti E; Clivio A; Nicolini G; Fogliata A
Radiother Oncol; 2008 Nov; 89(2):180-91. PubMed ID: 18692929
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
Milby AB; Both S; Ingram M; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
19. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancer.
Kuipers SC; Godart J; Corbeau A; Breedveld S; Mens JWM; de Boer SM; Nout RA; Hoogeman MS
Radiother Oncol; 2024 Jun; 195():110222. PubMed ID: 38471634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
